Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Frank Mitsch
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).
- Questions
- 32on tracked calls
- Challenge rate
- 13%4 of 32 questions
- Companies
- 6questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 32 of 32 questions from 6 companies
LYBLyondellBasell7 questions · 7 reporting periods · 2 of 7 challenging
Calendar 2026 Q2
I wanted to come back to the $250 million negative impact in 2Q from the Bayport outage.
Show response
Ledet cautioned against simply adding the $250M back, citing POSM-to-PO/TBA mix shifts and uncertain crude prices and gasoline crack spreads, but expects improved PO and MTBE volumes.
Calendar 2026 Q1
You said 75% given the outages that you have. But you said that you're going to end it at 95% to 100% when you get everything back up and running
Show response
Aaron noted they will run all available capacity at full rates once Bayport returns but cautioned against using the 95-100% figure literally due to La Porte acid unit limitations. Peter added he visited Bayport 10 days ago and confirmed all hands on deck with target restart by end of Q2.
Calendar 2025 Q4
what might be the possibility that Lyondell would look to monetize that asset should some of the refiners look at, hey, the Ven crude becomes more plentiful
Show response
Peter noted shutting the refinery avoided ~$1.5B in deferred turnaround CapEx. Other US refineries can process Venezuelan crude. Plan for refinery site continues as previously communicated (MoReTec-2 when market/cash conditions allow). Remains open to options for existing assets.
Calendar 2025 Q3
to summarize your thoughtful response on the dividend is that, yes, we will pay it in the near term. Am I interpreting that correctly
Show response
Peter did not explicitly confirm or deny continued dividend payments beyond near-term, instead emphasizing cash conversion focus, execution track record, and team alignment. On Q4: deliberate decision to pull forward maintenance to avoid 2026 downtime. PE price increases on table. Aaron noted MTBE premiums carried from September into October with 20% of USGC capacity still offline into November. Peter added gasoline inventories materially lower than seasonal norms.
Calendar 2025 Q2
I'm curious, given that you're not really earning in terms of operating cash flow, the shareholder returns in form of dividend and buybacks, if you could expand upon your thoughts on the dividend a...
Show response
Peter confirmed Q3 dividend of $1.37/share. Emphasized LYB started 2025 with $3.4B cash (same as beginning of 2024). Targeting minimum $1.4B cash balance but can manage lower through cycle. Total liquidity $6.35B. Halted further share buybacks for 2025-2026. Cash improvement plan on track for $1.1B over 2025-2026.
Calendar 2025 Q1
I was curious as to your thoughts on buybacks during this period
Show response
Peter confirmed 14 consecutive years of dividend increases, believes LYB well positioned to continue. Agustin noted $110M Q1 buybacks more than offset dilution. Peter hinted buybacks likely continued at depressed share prices post-Q1.
Calendar 2024 Q4
How do you view the margin profile for polyethylene playing out as we move through the first quarter
Show response
Kim Foley noted $0.05-0.06/lb ethylene cost increase, 7 and 5 cent PE price increases announced, and 5% of industry crackers coming offline. Expressed confidence in Q1 price improvement given tight supply.
DDDuPont6 questions · 3 reporting periods · 0 of 6 challenging
Calendar 2025 Q2
the adjustment downward of the tariff impact from $60 million to $20 million, can you provide any more context on the $20 million?
Show response
Franzen explained $20M assumes 90-day pause holds through year-end, with some EU/India tariffs added but latest news not yet incorporated.
the Chinese investigation into Tyvek was dismissed. I was curious if you have any further dialogue with the Chinese?
Show response
Koch confirmed investigation suspended and closed with no further investigations or dialogue.
Calendar 2025 Q1
How are your order books looking April, May for 2Q relative to how they are historically?
Show response
Franzen confirmed strong April orders, 75% book-to-bill starting point for IndustrialsCo with normal seasonal pickup in orders.
I believe that initially there was a thought that the Healthcare and Water side would grow mid to-high single-digits, and having done low-teens in the first-quarter
Show response
Koch maintained full-year targets (Healthcare high-single, Water mid-to-high-single) with Q1 outperformance partly from favorable comps.
Calendar 2024 Q4
I'm curious as to what went right or what exceeded your expectations in November and December?
Show response
Koch attributed the beat primarily to Electronics strength, with Water and medical packaging also exceeding expectations, plus a lower Q4 tax rate.
the segments that you thought were doing better, i.e., Water Packaging, et cetera, that has that continued at that pace
Show response
Koch confirmed early 2025 trends are tracking to expectations, a brief but direct confirmation of momentum.
DOWDow Inc.6 questions · 6 reporting periods · 1 of 6 challenging
Calendar 2026 Q2
can you talk about why P&SP came in below the expectations that you had laid out back in April
Show response
Carter and Tate explained the June $0.15 PE price decline and unplanned events hit P&SP, offset by stronger II&I margins and a land sale, landing near the updated guide.
Calendar 2026 Q1
could you speak to the future of what your expectations are for Sadara over the next couple of years? Can you speak to whatever damage may have been sustained so far to that facility?
Show response
Fitterling said Sadara damage limited, most intercepted. Restructuring with Aramco ongoing as leverage/balance sheet issue not operating problem. Update expected midyear. Tate confirmed Q1 equity loss $115M, full-year estimate approximately $400M from Sadara.
Calendar 2025 Q4
are you getting confident in the ability of AI to help achieve these productivity savings?
Show response
Fitterling described end-to-end process reengineering beyond AI: intelligent data hub enabling automation, legal patent/discovery savings, drones/crawlers replacing scaffolding in turnarounds. Growth side refocuses sales in growing geographies.
Calendar 2025 Q2
Can you kind of size the buckets for us in terms of how much that was the $0.03 decline from April?
Show response
Carter attributed miss roughly 50/50 between the $0.03/lb April price decline and operating rate reductions driven by tariff-related export disruption.
Calendar 2025 Q1
I was wondering if you could comment on the free cash flow expectations for 2Q relative to negative five eighty for January
Show response
Tate noted $2.4B Macquarie proceeds in Q2 but similar working capital use. Carter highlighted downstream silicones growth in electronics and AI applications. Fitterling noted positive siloxane pricing moves into Q2.
Calendar 2024 Q4
Can you talk about what you're seeing in terms of the pace of business between the polyurethanes and Construction and Industrial Solutions segments?
Show response
Carter noted no recovery in polyurethanes despite rate cuts, auto inventories at 10-year highs. Industrial Solutions stable with green shoots in energy and pharma.
PPGPPG Industries6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
Can you talk about the sustainability of your market shares in both Refinish and in auto OEM?
Show response
Direct, distinguishing step-change share gains in auto OEM from incremental singles and doubles in Refinish.
Calendar 2026 Q1
I was wondering how you look at the potential for free cash flow generation in 2026?
Show response
Morales noted cash from ops up about $50 million vs prior year with capital spending lower than prior year. Cash forecast unchanged from January. Knavish provided proxy: cash flow approximately 10% of sales. Priorities: dividend, organic investments (aerospace), selective M&A, and share repurchases (10 straight quarters). Morales retiring after approximately 80 conference calls.
Calendar 2025 Q4
you described the first half as being low single-digit EPS growth. And in your comments this morning, you talked about it being flat to low single digits
Show response
Knavish clarified H1 phasing: Q1 flattish EPS growth, Q2 low single digits, ramping to stronger H2. Progression reflects refinish destocking fading through the year.
Calendar 2025 Q2
can you talk about the order patterns that you saw throughout the second quarter and what you're seeing so far here in the third quarter from your customers that may be anomalous
Show response
Morales said early April saw customer concerns but normal patterns returned through the quarter. No pull-forward into Q2. FX: negative Q1, less negative Q2, back half expected to offset Q1, year-to-date near zero.
Calendar 2025 Q1
I suspect we should probably start thinking about Performance Coatings organically up in 2025, moving that up to high single digits, low double digits. So, curious to comment on that
Show response
Knavish confirmed total company low-single-digit organic growth, Performance Coatings mid-single-digits for full year. Industrial share gains ($100M) on track, some pulled forward. Morales noted Performance Coatings faces harder H2 comps while Industrial gets easier comps.
Calendar 2024 Q4
when all is said and done with respect to the divestiture of North American architectural, you know, a creative neutral dilutive
Show response
Morales confirmed proceeds received late Q4 2024 being deployed via $400M Q1 buyback. Knavish clearly stated accretive and discussed M&A strategy remaining disciplined.
QQnity Electronics, Inc.4 questions · 2 reporting periods · 0 of 4 challenging
Calendar 2026 Q2
how should we think about the near term? What’s your visibility there? And can we expect this 20% growth
Show response
Kemp declined to give a quarterly advanced-node rate but said broad commercialization across logic and memory leaders is driving it; portfolio at ~40% advanced nodes.
what you expect MSI growth to be for the, for the broader industry here in ’26?
Show response
Goss gave a specific industry view: MSI high single digits and PCB mid-to-high single digits for 2026.
Calendar 2026 Q1
What may have surprised you in March if that is indeed true? And if so, does that continue in April and beyond?
Show response
Kemp attributed upside to ICS strength exceeding seasonal patterns plus mature logic restocking. Goss added strong order books and chance to do even better if conditions improve.
How do you think about working capital use throughout the year?
Show response
Goss confirmed healthy working capital metrics with inventory turns around 6x. Expects AR to grow modestly with sales but overall in good shape.
CTVACorteva3 questions · 3 reporting periods · 1 of 3 challenging
Calendar 2026 Q2
can you kind of square why we are seeing the price degradation as much as we are given that 2 thirds is differentiated
Show response
Magro said new products are essentially flat on price with volume up, while off-patent molecules under generic pressure in Brazil drove the cut.
Calendar 2025 Q2
I was wondering if you could opine on what your expectations were for share gains in both corn and soy?
Show response
Judd confirmed share gains in corn and soy with strong PowerCore/Vorceed and Brevant retail success. Chuck said 2026 likely sees slight shift back to soybeans from corn but both will be planted heavily.
Calendar 2024 Q4
on the inventory side, typically, you see a build for Corteva, Inc. Q4 versus Q3. That didn't happen this year
Show response
David attributed Q4 inventory draw to clearing higher-cost CP inventory from prior year and strong Q4 volumes. 2025 working capital expected to be ~$100M headwind, back to normal levels.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| LYB LyondellBasell | 7 | 29%2 of 7 questions |
| DD DuPont | 6 | 0%none of 6 questions |
| DOW Dow Inc. | 6 | 17%1 of 6 questions |
| PPG PPG Industries | 6 | 0%none of 6 questions |
| Q Qnity Electronics, Inc. | 4 | 0%none of 4 questions |
| CTVA Corteva | 3 | 33%1 of 3 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 6 | 0%none of 6 questions | 5 |
| 2025 Q1 | 5 | 0%none of 5 questions | 4 |
| 2025 Q2 | 6 | 17%1 of 6 questions | 5 |
| 2025 Q3 | 1 | 100%1 of 1 question | 1 |
| 2025 Q4 | 3 | 0%none of 3 questions | 3 |
| 2026 Q1 | 5 | 0%none of 5 questions | 4 |
| 2026 Q2 | 6 | 33%2 of 6 questions | 5 |
- 2024 Q46 questions · challenge rate 0% (none of 6 questions) · 5 companies
- 2025 Q15 questions · challenge rate 0% (none of 5 questions) · 4 companies
- 2025 Q26 questions · challenge rate 17% (1 of 6 questions) · 5 companies
- 2025 Q31 question · challenge rate 100% (1 of 1 question) · 1 company
- 2025 Q43 questions · challenge rate 0% (none of 3 questions) · 3 companies
- 2026 Q15 questions · challenge rate 0% (none of 5 questions) · 4 companies
- 2026 Q26 questions · challenge rate 33% (2 of 6 questions) · 5 companies
Topics
Topics tagged on this analyst’s questions.
- Capital Allocation10
- Demand8
- Margin7
- Pricing6
- Revenue Growth6
- Competitive Dynamics4
- Supply Chain3
- Innovation & R&D2
- Macroeconomic2
- Guidance Reliability2
Show all 15 topics
- Cost Pressure1
- Trade Tariffs1
- Regulation Policy1
- Fx1
- M&A1